Reata

Quote

anonymous

Guest
After many years and what appears to be 2 unsuccessful attempts to get approval, looks like they may finally be done. Sad news to all who were just hired for launch.
 






Had they even started interviewing for territory representatives? I think just managers were put in place. It’s a shame product looked to be promising on various fronts!
 












For the longest time, they had a single candidate (bardoxolone), which was a drug in search of an indication. Then they had the second candidate, omaveloxolone, which they are trying in some other indications. They seem to be stuck on derivatives of olive oil. Do these guys own an olive farm or something? They’ve tried and failed so many times, their investors have to be getting a little more than ticked off at the decades of failures,
 












Top Bottom
Back
Quote